UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women

Journal of clinical oncology, 2011-11, Vol.29 (33), p.4373-4380

2011

Volltextzugriff (PDF)

GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (16), p.7849-7853

2006

Volltextzugriff (PDF)

Phase II Studies of Gemcitabine and Cisplatin in Heavily and Minimally Pretreated Metastatic Breast Cancer

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2163-2169

2009

Volltextzugriff (PDF)

Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast

Breast cancer research and treatment, 2009-11, Vol.118 (1), p.161-168

2009

Volltextzugriff (PDF)

Preoperative Twice-Weekly Paclitaxel With Concurrent Radiation Therapy Followed by Surgery and Postoperative Doxorubicin-Based Chemotherapy in Locally Advanced Breast Cancer: A Phase I/II Trial

Journal of clinical oncology, 2003-03, Vol.21 (5), p.864-870

2003

Volltextzugriff (PDF)

Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation

Breast cancer research and treatment, 2012-04, Vol.132 (2), p.653-660

2012

Volltextzugriff (PDF)

Tamoxifen, Soy, and Lifestyle Factors in Asian American Women With Breast Cancer

Journal of clinical oncology, 2007-07, Vol.25 (21), p.3024-3030

2007

Volltextzugriff (PDF)

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Clinical cancer research, 2007-01, Vol.13 (2), p.654-658

2007

Volltextzugriff (PDF)

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial

Contraception (Stoneham), 2012-09, Vol.86 (3), p.238-243

2012

Volltextzugriff (PDF)

GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy

International journal of cancer, 2011-02, Vol.128 (3), p.726-731

2011

Volltextzugriff (PDF)

Reversal of Gonadotropin-releasing Hormone Agonist Induced Reductions in Mammographic Densities on Stopping Treatment

Cancer epidemiology, biomarkers & prevention, 2001-11, Vol.10 (11), p.1117-1120

2001

Volltextzugriff (PDF)

Mammographic Density Changes During the Menstrual Cycle

Cancer epidemiology, biomarkers & prevention, 2001-02, Vol.10 (2), p.141-142

2001

Volltextzugriff (PDF)

Changes in Mammographic Densities Induced by a Hormonal Contraceptive Designed to Reduce Breast Cancer Risk

JNCI : Journal of the National Cancer Institute, 1994-03, Vol.86 (6), p.431-436

1994

Volltextzugriff (PDF)

Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival

Breast cancer research and treatment, 2010-12, Vol.124 (3), p.723-732

2010

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Evaluation of the Glycinamide Ribonucleotide Formyltransferase Inhibitor AG2034

Clinical cancer research, 2000-07, Vol.6 (7), p.2677-2684

2000

Volltextzugriff (PDF)

Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics

Cancer research (Chicago, Ill.), 1988-01, Vol.48 (2), p.459-461

1988

Volltextzugriff (PDF)

Problems Involved in Including Women with Simple Hysterectomy in Epidemiologic Studies Measuring the Effects of Hormone Replacement Therapy on Breast Cancer Risk

American journal of epidemiology, 1998-04, Vol.147 (8), p.718-721

1998

Volltextzugriff (PDF)

Low HER2/ neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer

International journal of radiation oncology, biology, physics, 2002-02, Vol.52 (2), p.397-405

2002

Volltextzugriff (PDF)

Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome

Fertility and sterility, 1994-11, Vol.62 (5), p.932-937

1994

Volltextzugriff (PDF)

Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-Fluorouracil and radiation therapy

International journal of radiation oncology, biology, physics, 1997-12, Vol.39 (5), p.1059-1068

1997

Volltextzugriff (PDF)

Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation

Cancer chemotherapy and pharmacology, 2000-01, Vol.45 (2), p.103-110

2000

Volltextzugriff (PDF)

Effect of valspodar on the pharmacokinetics of unbound paclitaxel

Investigational new drugs, 2003-08, Vol.21 (3), p.291-298

2003

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil

Clinical cancer research, 1996-09, Vol.2 (9), p.1461-1467

1996

Volltextzugriff (PDF)

Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks

Cancer chemotherapy and pharmacology, 2000, Vol.45 (5), p.423-427

2000

Volltextzugriff (PDF)

The Endocrine Prevention of Breast Cancer

Cancer investigation, 1995, Vol.13 (5), p.495-504

1995

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

Humans
(32)
Life Sciences & Biomedicine
(32)
Medical Sciences
(32)
Science & Technology
(32)
Female
(31)
Oncology
(27)
Adult
(26)
Middle Aged
(19)
Gynecology. Andrology. Obstetrics
(17)
Pharmacology. Drug Treatments
(17)
Antineoplastic Agents
(14)
Mammary Gland Diseases
(14)
Tumors
(14)
Aged
(13)
Breast Cancer
(8)
Breast Neoplasms - Drug Therapy
(8)
Chemotherapy
(8)
Breast Neoplasms - Prevention & Control
(7)
Male
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women

GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer

Phase II Studies of Gemcitabine and Cisplatin in Heavily and Minimally Pretreated Metastatic Breast Cancer

Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast

Preoperative Twice-Weekly Paclitaxel With Concurrent Radiation Therapy Followed by Surgery and Postoperative Doxorubicin-Based Chemotherapy in Locally Advanced Breast Cancer: A Phase I/II Trial

Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation

Tamoxifen, Soy, and Lifestyle Factors in Asian American Women With Breast Cancer

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial

GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy

Reversal of Gonadotropin-releasing Hormone Agonist Induced Reductions in Mammographic Densities on Stopping Treatment

Mammographic Density Changes During the Menstrual Cycle

Changes in Mammographic Densities Induced by a Hormonal Contraceptive Designed to Reduce Breast Cancer Risk

Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival

Pharmacokinetic and Pharmacodynamic Evaluation of the Glycinamide Ribonucleotide Formyltransferase Inhibitor AG2034

Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics

Problems Involved in Including Women with Simple Hysterectomy in Epidemiologic Studies Measuring the Effects of Hormone Replacement Therapy on Breast Cancer Risk

Low HER2/ neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer

Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome

Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-Fluorouracil and radiation therapy

Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation

Effect of valspodar on the pharmacokinetics of unbound paclitaxel

Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil

Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks

The Endocrine Prevention of Breast Cancer

Aktive Filter

Suchergebnisse filtern